{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:37:16Z","timestamp":1761597436372},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Mycobacterium bovis<\/jats:italic> bacillus Calmette Gu\u00e9rin (BCG) vaccine, which has been inoculated to more than one billion people world-wide, has significant effect in preventing tuberculous meningitis and miliary tuberculosis (TB) in neonate and early childhood. However, BCG fails to adequately protect against pulmonary TB and reactivation of latent infections in adults. To overcome this problem, adequate booster is urgently desired in adult who received prior BCG vaccination, and appropriate animal models that substitute human cases would be highly valuable for further experimentation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings<\/jats:title>\n            <jats:p>The booster effect of the synthesized CpG oligomer (Oligo-B) on aged mice which had been primarily vaccinated with BCG at the age of 4-week old. The specific Th1 type reaction, production of interferon-\u03b3, in response to TB antigens, purified protein derivatives (PPD) and protection against challenge with <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (MTB) H<jats:sub>37<\/jats:sub>Rv decreased with increasing age and were not observed in 89-week old mice. In order to rejuvenate the Th1 type response against PPD and protection activity against MTB infection, Oligo-B, which is known to augment Th1 responses, was administered as a booster to 81-90-week old mice (late 50\u2019s in human equivalent) vaccinated with BCG at 4-week old. The boosting with Oligo-B increased the number of CD4<jats:sup>+<\/jats:sup> CD44<jats:sup>high<\/jats:sup> CD62L<jats:sup>high<\/jats:sup>, central memory type T cell. Furthermore, the Oligo-B boosting rejuvenated the ability of mice to protect against infection with MTB H<jats:sub>37<\/jats:sub>Rv.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Th1-adjuvant CpG oligo DNA, such as Oligo-B, may be a promising booster when coupled with BCG priming.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-4933-10-25","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T22:13:59Z","timestamp":1371939239000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG"],"prefix":"10.1186","volume":"10","author":[{"given":"Keiichi","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemasa","family":"Takii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saburo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Maeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiko","family":"Iho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narushi","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohkichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuji","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saotomo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikuo","family":"Onozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,22]]},"reference":[{"key":"150_CR1","volume-title":"BCG (Tuberculosis)","author":"WHO","year":"2011","unstructured":"WHO: BCG (Tuberculosis). 2011, http:\/\/www.who.int\/biologicals\/areas\/vaccines\/bcg\/Tuberculosis\/en\/,"},{"key":"150_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","volume":"2","author":"PD Hart","year":"1977","unstructured":"Hart PD, Sutherland I: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J. 1977, 2: 293-295. 10.1136\/bmj.2.6082.293.","journal-title":"Br Med J"},{"key":"150_CR3","first-page":"371","volume":"46","author":"WHO","year":"1972","unstructured":"WHO: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bull World Health Organ. 1972, 46: 371-385.","journal-title":"Bull World Health Organ"},{"key":"150_CR4","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1128\/IAI.69.4.2714-2717.2001","volume":"69","author":"JV Brooks","year":"2001","unstructured":"Brooks JV, Frank AA, Keen MA, Bellisle JT, Orme IM: Boosting vaccine for tuberculosis. Infect Immun. 2001, 69: 2714-2717. 10.1128\/IAI.69.4.2714-2717.2001.","journal-title":"Infect Immun"},{"key":"150_CR5","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.vaccine.2012.02.036","volume":"30","author":"MJ Brennan","year":"2012","unstructured":"Brennan MJ, Clagett B, Fitzgerald H, Chen V, Williams A, Izzo AA, Barker LF: Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Vaccine. 2012, 30: 2811-2823. 10.1016\/j.vaccine.2012.02.036.","journal-title":"Vaccine"},{"key":"150_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.molmed.2012.06.003","volume":"18","author":"B Broux","year":"2012","unstructured":"Broux B, Markovic-Plese S, Stinissen P, Hellings N: Pathogenic features of CD4(+)CD28(\u2212) T cells in immune disorders. Trends Mol Med. 2012, 18: 446-453. 10.1016\/j.molmed.2012.06.003.","journal-title":"Trends Mol Med"},{"key":"150_CR7","first-page":"374","volume":"2","author":"L Haynes","year":"2011","unstructured":"Haynes L, Lefebvre JS: Age-related Deficiencies in Antigen-Specific CD4 T cell Responses: Lessons from Mouse Models. Aging Dis. 2011, 2: 374-381.","journal-title":"Aging Dis"},{"key":"150_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/gerona\/glr237","volume":"67","author":"N Lee","year":"2012","unstructured":"Lee N, Shin MS, Kang I: T-cell biology in aging, with a focus on lung disease. J Gerontol A Biol Sci Med Sci. 2012, 67: 254-263.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"150_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1742-4933-7-12","volume":"7","author":"T Ito","year":"2010","unstructured":"Ito T, Takii T, Maruyama M, Hayashi D, Wako T, Asai A, Horita Y, Taniguchi K, Yano I, Yamamoto S, Onozaki K: Effectiveness of BCG vaccination to aged mice. Immun Ageing. 2010, 7: 12-10.1186\/1742-4933-7-12.","journal-title":"Immun Ageing"},{"key":"150_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1128\/CVI.00368-09","volume":"17","author":"MI Henao-Tamayo","year":"2010","unstructured":"Henao-Tamayo MI, Ordway DJ, Irwin SM, Shang S, Shanley C, Orme IM: Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol. 2010, 17: 618-625. 10.1128\/CVI.00368-09.","journal-title":"Clin Vaccine Immunol"},{"key":"150_CR11","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","volume":"182","author":"T Lindenstrom","year":"2009","unstructured":"Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P: Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol. 2009, 182: 8047-8055. 10.4049\/jimmunol.0801592.","journal-title":"J Immunol"},{"key":"150_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1348-0421.1992.tb02102.x","volume":"36","author":"S Yamamoto","year":"1992","unstructured":"Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O, Kataoka T, Tokunaga T: DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol. 1992, 36: 983-997.","journal-title":"Microbiol Immunol"},{"key":"150_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.vaccine.2008.12.025","volume":"27","author":"J Maeyama","year":"2009","unstructured":"Maeyama J, Komiya T, Takahashi M, Isaka M, Goto N, Yamamoto S: The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid. Vaccine. 2009, 27: 1166-1173. 10.1016\/j.vaccine.2008.12.025.","journal-title":"Vaccine"},{"key":"150_CR14","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1016\/j.vaccine.2011.07.051","volume":"29","author":"Y Ozeki","year":"2011","unstructured":"Ozeki Y, Hirayama Y, Takii T, Yamamoto S, Kobayashi K, Matsumoto S: Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guerin. Vaccine. 2011, 29: 6881-6887. 10.1016\/j.vaccine.2011.07.051.","journal-title":"Vaccine"},{"key":"150_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1084\/jem.161.5.1237","volume":"161","author":"YT Kim","year":"1985","unstructured":"Kim YT, Goidl EA, Samarut C, Weksler ME, Thorbecke GJ, Siskind GW: Bone marrow function I. Peripheral T cells are responsible for the increased auto-antiidiotype response of older mice. J Exp Med. 1985, 161: 1237-1242. 10.1084\/jem.161.5.1237.","journal-title":"J Exp Med"},{"key":"150_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0889-8561(02)00056-5","volume":"23","author":"H Bruunsgaard","year":"2003","unstructured":"Bruunsgaard H, Pedersen BK: Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am. 2003, 23: 15-39. 10.1016\/S0889-8561(02)00056-5.","journal-title":"Immunol Allergy Clin North Am"},{"key":"150_CR17","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1128\/IAI.68.5.2948-2953.2000","volume":"68","author":"BL Freidag","year":"2000","unstructured":"Freidag BL, Melton GB, Collins F, Klinman DM, Cheever A, Stobie L, Suen W, Seder RA: CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis. Infect Immun. 2000, 68: 2948-2953. 10.1128\/IAI.68.5.2948-2953.2000.","journal-title":"Infect Immun"},{"key":"150_CR18","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1016\/j.vaccine.2011.07.039","volume":"29","author":"M Ballester","year":"2011","unstructured":"Ballester M, Nembrini C, Dhar N, De Titta A, De Piano C, Pasquier M, Simeoni E, van der Vlies AJ, McKinney JD, Hubbell JA, Swartz MA: Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine. 2011, 29: 6959-6966. 10.1016\/j.vaccine.2011.07.039.","journal-title":"Vaccine"},{"key":"150_CR19","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1016\/j.vaccine.2009.05.049","volume":"27","author":"BD Silva","year":"2009","unstructured":"Silva BD, Da Silva EB, Do Nascimento IP, Dos Reis MC, Kipnis A, Junqueira-Kipnis AP: MPT-51\/CpG DNA vaccine protects mice against Mycobacterium tuberculosis. Vaccine. 2009, 27: 4402-4407. 10.1016\/j.vaccine.2009.05.049.","journal-title":"Vaccine"},{"key":"150_CR20","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1128\/IAI.00580-09","volume":"77","author":"DM Da Fonseca","year":"2009","unstructured":"Da Fonseca DM, Silva CL, Wowk PF, Paula MO, Ramos SG, Horn C, Marchal G, Bonato VL: Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion. Infect Immun. 2009, 77: 5311-5321. 10.1128\/IAI.00580-09.","journal-title":"Infect Immun"},{"key":"150_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","volume":"20","author":"AM Krieg","year":"2002","unstructured":"Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002, 20: 709-760. 10.1146\/annurev.immunol.20.100301.064842.","journal-title":"Annu Rev Immunol"},{"key":"150_CR22","first-page":"33","volume":"119","author":"T Ito","year":"2009","unstructured":"Ito T, Schaller M, Hogaboam CM, Standiford TJ, Sandor M, Lukacs NW, Chensue SW, Kunkel SL: TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest. 2009, 119: 33-46.","journal-title":"J Clin Invest"},{"key":"150_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cyto.2007.11.022","volume":"41","author":"SA Khader","year":"2008","unstructured":"Khader SA, Cooper AM: IL-23 and IL-17 in tuberculosis. Cytokine. 2008, 41: 79-83. 10.1016\/j.cyto.2007.11.022.","journal-title":"Cytokine"},{"key":"150_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tube.2012.05.008","volume":"92","author":"L Ancelet","year":"2012","unstructured":"Ancelet L, Rich FJ, Delahunt B, Kirman JR: Dissecting memory T cell responses to TB: Concerns using adoptive transfer into immunodeficient mice. Tuberculosis (Edinb). 2012, 92: 422-433. 10.1016\/j.tube.2012.05.008.","journal-title":"Tuberculosis (Edinb)"},{"key":"150_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/eji.201141903","volume":"42","author":"JK Nambiar","year":"2012","unstructured":"Nambiar JK, Pinto R, Aguilo JI, Takatsu K, Martin C, Britton WJ, Triccas JA: Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory. Eur J Immunol. 2012, 42: 385-392. 10.1002\/eji.201141903.","journal-title":"Eur J Immunol"}],"container-title":["Immunity &amp; Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4933-10-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:42:11Z","timestamp":1630543331000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/1742-4933-10-25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,22]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["150"],"URL":"https:\/\/doi.org\/10.1186\/1742-4933-10-25","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,22]]},"assertion":[{"value":"31 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}